Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
4.719M
Cash
1.638M
Avg Qtr Burn
-867K
Short % of Float
4.86%
Insider Ownership
18.72%
Institutional Own.
15.75%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LB-100 +atezolizumab Details Cancer, Metastatic colorectal cancer | Phase 1 Data readout |